Questions on flavored vaping products dominated the Nov. 20 Senate confirmation hearing for Stephen M. Hahn, the administration’s pick for the job of FDA commissioner.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
